Cancer Research
- This Pond Scum Could Be The Key To New Cancer Therapies
-
Cyanobacteria, also referred to as blue-green algae or pond scum, is found in nearly every habitat, from oceans to fresh water to bare rocks to soil, and is a source of many unique chemical structures. Researchers at the University of Illinois at Chicago ( ...
Article - News Staff - Jul 22 2008 - 12:18am
- First Cancer Diagnostic Test Based On Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval
-
REHOVOT, Israel and JERSEY CITY, New Jersey, July 22 /PRNewswire/--- Test Developed and Validated by Columbia University Medical Center Based on Rosetta Genomics' Proprietary MicroRNA Technology- The Test Differentiates Squamous From Non-Squamous Non ...
Article - Anna Ohlden - Jul 22 2008 - 8:32am
- Sparta Systems Demonstrates Continued Expansion In Global Life Science Markets
-
HOLMDEL, New Jersey, July 22 /PRNewswire/--- New European customers signify worldwide requirements for quality management and regulatory compliance solutions Sparta Systems, Inc. (Sparta), the maker of TrackWise(R), and the market leader in enterprise qua ...
Article - Anna Ohlden - Jul 22 2008 - 11:31am
- How Safe Are Cell Phones? This Cancer Center Director Thinks Not Very
-
Ronald B. Herberman, MD, the director of the University of Pittsburgh Cancer Institute and UPMC Cancer Centers, issued the following directive to thousands of University of Pittsburgh employees: ******************************* FROM: Ronald B. Herberman, MD ...
Article - News Staff - Jul 23 2008 - 9:51pm
- Rosetta Genomics Completes Acquisition Of Parkway Clinical Laboratories Inc.
-
REHOVOT, Israel and JERSEY CITY, New Jersey, July 24 /PRNewswire/-- Rosetta Genomics Ltd. (Nasdaq: ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced today that it has successfully completed the acquisition of Par ...
Article - Anna Ohlden - Jul 24 2008 - 2:33am
- Studies Assessed By European Health Authority Conclude That Impurity In Roche's Viracept(R) (nelfinavir Mesylate) Did Not Increa
-
BASEL, Switzerland, July 24 /PRNewswire/-- The European Committee for Human Medicinal Products (CHMP) has confirmed that the presence of an impurity called ethyl methanesulfonate (EMS) in Roche's Viracept (nelfinavir mesylate) did not increase patien ...
Article - Anna Ohlden - Jul 24 2008 - 10:33am
- Red, White, And Blood
-
If the drinker paradox states that in any pub there is a customer such that, if he or she drinks, everybody in the pub drinks and the diamond-water paradox states that water is more useful than diamonds, yet is a lot cheaper, then the French paradox that t ...
Article - Audrey Amara - Jul 24 2008 - 11:45am
- Molecular Link Between Circadian Rhythm And Metabolism
-
UC Irvine researchers have found a molecular link between circadian rhythms, our body clock, and metabolism. The discovery reveals new possibilities for the treatment of diabetes, obesity and other related diseases. Circadian rhythms of 24 hours govern fun ...
Article - News Staff - Jul 24 2008 - 1:30pm
- Balance In The Bones
-
As Albert Einstein once said about balance, "Life is like riding a bicycle. To keep your balance you must keep moving." The same is true of bone mineral density in testing for breast cancer—balance is better. The September 2008 issue of “CANCER” ...
Article - Audrey Amara - Jul 25 2008 - 5:17pm
- Metals Helping Cure Cancer
-
A collaboration between chemists and biologists has made it possible to identify the effects of a new class of molecules, polyoxometalates, primarily composed of metals and oxygen. Polyoxometalates are anionic inorganic metal oxide structures that have val ...
Article - News Staff - Jul 26 2008 - 10:30am